Recalls

All Class I Class II Class III

14,688 recalls

II Oasis Tears PF, Preservative-Free Lubricant Eye Drops, 10mL/0.34 Fl OZ Bottle, Sterile, Manufactured for: OASIS Medical,… Lack of Assurance of Sterility: The recall is being initiated out of an abundance of caution following FDA observations… Oasis Medical, Inc. · May 20, 2026 II TPN bag (patient specific), Rx# 11-4909703-0-1, Compound Volume 1660 mL per bag, Rx only, Single Dose Injection, Refrige… Incorrect Product Formulation: product did not contain insulin as listed in the label. Central Admixture Pharmacy Services, Inc (CAPS) Los Angeles · May 13, 2026 II NAPROXEN ORAL SUSPENSION, USP, 125 mg/5mL, Rx only, 16fl oz (473 mL) bottles, Distributed by: Acella Pharmaceuticals, LL… Chemical contamination; presence of lead and lithium above specification Acella Pharmaceuticals, LLC · May 13, 2026 II Duloxetine Delayed-Release Capsules USP, 60mg, Rx Only, 90-count bottle, Mfr. CGMP Deviations; presence of N-nitroso-duloxetine impurity above the FDA recommended limit Breckenridge Pharmaceutical, Inc. · May 13, 2026 II Enalapril Maleate Tablets, USP, 20 mg, 1,000-count bottle, Rx only, Manufactured by: Unique Pharmaceutical Laboratories… Failed Impurities/Degradation Specifications:Out of specification result occurred in Organic Impurities Test JB Chemicals and Pharmaceuticals Ltd · May 13, 2026 II Octreotide Acetate for Injectable Suspension, for gluteal intramuscular use, 30 mg, In Single-Dose kits containing: 8-mL… Lack of Assurance of Sterility: Quality system deficiencies identified during a routine U.S Food and Drug Administration… Teva Pharmaceuticals USA, Inc · May 13, 2026 II BD PurPrep, Povidone-iodine 8.3% w/w (0.83% available iodine) with isopropyl alcohol 72.5% w/w Sterile Solution, 0.36 fl… Lack of assurance of Sterility: potential product contamination CareFusion 213, LLC · May 13, 2026 II BD PurPrep, Povidone-iodine 8.3% w/w (0.83% available iodine) with isopropyl alcohol 72.5% w/w Sterile Solution, 25x26mL… Lack of assurance of Sterility: potential product contamination CareFusion 213, LLC · May 13, 2026 II Duloxetine Delayed-Release Capsules, 20 mg, Rx Only, 60 capsules, Marketed by: Ajanta Pharma USA Inc., Bridgewater, NJ 0… CGMP Deviations: Presence of N-nitroso-Duloxetine impurity above FDA recommended limit of 0.83 ppm, identified at the 12… Ajanta Pharma Ltd. · May 13, 2026 II Duloxetine Delayed-Release Capsules, 60 mg, Rx Only, 30 capsules, Marketed by: Ajanta Pharma USA Inc., Bridgewater, NJ 0… CGMP Deviations: Presence of N-nitroso-Duloxetine impurity above FDA recommended limit of 0.83 ppm, identified at the 12… Ajanta Pharma Ltd. · May 13, 2026 II Duloxetine Delayed-Release Capsules, 30 mg, Rx Only, a) 90 Capsules, NDC 27241-098-09, b) 30 capsules, NDC 27241-098-03,… CGMP Deviations: Presence of N-nitroso-Duloxetine impurity above FDA recommended limit of 0.83 ppm, identified at the 12… Ajanta Pharma Ltd. · May 13, 2026 II DELFLEX, Dextrose Peritoneal Dialysis Solution with attached stay-safe Exchange Set for Intraperitoneal Dialysis Only, 2… Lack of Assurance of Sterility: Potential leaks from perforations in bags. Fresenius Medical Care Holdings, Inc. · May 13, 2026 II DELFLEX, Dextrose Peritoneal Dialysis Solution with attached stay-safe Exchange Set for Intraperitoneal Dialysis Only, 1… Lack of Assurance of Sterility: Potential leaks from perforations in bags. Fresenius Medical Care Holdings, Inc. · May 13, 2026 II Alendronate Sodium Oral Solution, 70 mg/75 mL, 75 mL, Rx only, 4 x 75 mL Single Dose Bottles, Distr. This recall is being conducted due to out of specification assay results in a limited number of bottles that were stored… Hikma Pharmaceuticals USA INC · May 6, 2026 II fentaNYL Citrate Injectable Solution in 0.9% Sodium Chloride, 50 mcg/5mL)(10 mcg per mL), wells pharma, NDC 73702-202-15… cGMP deviations. Wells Pharma of Houston LLC · May 6, 2026 II Ketamine Hydrochloride Injectable Solution, 50mg/ml, (50 mg per mL) Volume: 1 mL, 5265 Kitty Drive, Houston, TX 77054, N… cGMP deviations. Wells Pharma of Houston LLC · May 6, 2026 II fentaNYL Citrate Injectable Solution in 0.9% Sodium Chloride, 1000 mcg/50mL (20 mcg per mL), well pharma of Houston, NDC… cGMP deviations. Wells Pharma of Houston LLC · May 6, 2026 II fentaNYL Citrate Injectable Solution, Narcotic, CII, 1250 mcg/25mL (50 mcg per mL), 25 mL, wells pharma of Houston, NDC… cGMP deviations. Wells Pharma of Houston LLC · May 6, 2026 II fentaNYL Citrate injectable Solution in 0.9% Sodium Chloride, Narcotic, (2500 mcg/ 250 mL) (10 mcg per mL), 250 mL bag,… cGMP deviations. Wells Pharma of Houston LLC · May 6, 2026 II fentaNYL Citrate Injectable Solution, NARCOTIC, Cii, 1000 mcg/100 mL (10 mcg per mL), 100 mL bag, Wells Pharma in Housto… cGMP deviations. Wells Pharma of Houston LLC · May 6, 2026